-
Verona validation of the DAAE score, a tool for estimating risk of clinical disease progression in people with multiple sclerosis
Fuchs, T. A., Ziccardi, S., Jelgerhuis, J. R., Killestein, J., Strijbis, E. M. M., Zivadinov, R., Weinstock-Guttman, B., Schoonheim, M. M. & Calabrese, M., 1 Sept 2025, In: Multiple sclerosis and related disorders. 101, 106586.Research output: Contribution to journal › Article* › Academic › peer-review
-
A multi-domain lifestyle intervention in multiple sclerosis: a longitudinal observational study
Nauta, I. M., Loughlin, K. N. M., Gravesteijn, A. S., van Wegen, J., Hofman, R. P., Wilmsen, N., Coles, E., van Kempen, Z. L. E., Killestein, J., van Oosten, B. W., Strijbis, E. M. M., Uitdehaag, B. M. J. & de Jong, B. A., 1 Jul 2025, In: Journal of Neurology. 272, 7, 476.Research output: Contribution to journal › Article* › Academic › peer-review
-
Cognitive test performance and disease progression in primary and secondary progressive MS: An analysis of the SPRINT-MS study
Leavitt, V. M., Fox, R., Mostert, J., D’Haeseleer, M., Moral, E., Brieva-Ruiz, L., Repovic, P., Bowen, J. D., Comtois, J., Uitdehaag, B., Strijbis, E., Cutter, G. & Koch, M. W., Jun 2025, In: Multiple Sclerosis Journal. 31, 7, p. 866-876 11 p., 13524585251335213.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
